GFPT1 Gene (Glutamine-Fructose-6-Phosphate Transaminase 1)

Key enzyme in hexosamine biosynthesis pathway; associated with congenital myasthenic syndromes and metabolic disorders.

Gene Information Card

Symbol GFPT1
Full Name Glutamine-Fructose-6-Phosphate Transaminase 1
Gene Type Protein coding
Chromosomal Location 2p13.3
NCBI Gene ID 2673 ncbi.nlm.nih.gov/gene/2673
Ensembl ID ENSG00000115904
UniProt ID Q06210
OMIM ID 138292
HGNC ID 4241
Aliases GFAT1, GFAT, GFPT, GFAT1L

Description

GFPT1 encodes glutamine-fructose-6-phosphate transaminase 1, the rate-limiting enzyme of the hexosamine biosynthesis pathway. It catalyzes the conversion of fructose-6-phosphate and glutamine to glucosamine-6-phosphate, a precursor for N- and O-linked glycosylation. Mutations in GFPT1 are associated with congenital myasthenic syndrome (CMS) and may influence insulin resistance and diabetes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital Myasthenic Syndrome (CMS) Loss-of-function mutations impair glycosylation of acetylcholine receptor subunits, reducing synaptic efficiency. ClinVar, OMIM
Diabetes Mellitus (Type 2) Overexpression or increased activity of GFPT1 leads to elevated hexosamine flux, contributing to insulin resistance. NCBI, PubMed
Obesity Altered GFPT1 expression in adipose tissue affects hexosamine pathway and metabolic signaling. UniProt, literature

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal Muscle 12.5 Medium
Heart 10.3 Medium
Liver 8.7 Medium
Pancreas 6.2 Low
Brain 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 High expression
HepG2 11.8 Moderate expression
A549 9.4 Moderate expression
K562 4.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Loss of function; associated with CMS
c.643C>T (p.Arg215Trp) Missense Rare Impaired enzyme activity; CMS
c.1024G>A (p.Gly342Arg) Missense Rare Reduced catalytic efficiency; CMS
c.1498C>T (p.Arg500Cys) Missense Rare Dominant negative effect in some cases
Mutation functional classification

Loss of Function (LOF)

Most CMS-associated mutations reduce or abolish GFPT1 enzymatic activity, impairing hexosamine biosynthesis and glycosylation.

Gain of Function (GOF)

Not well documented; overexpression in metabolic tissues may contribute to insulin resistance.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg500Cys) may exert dominant-negative effects by interfering with dimerization.

Pathways

Hexosamine Biosynthesis Pathway (Reactome: R-HSA-446203)
Metabolism of carbohydrates (Reactome: R-HSA-71387)
O-linked glycosylation (Reactome: R-HSA-5173105)

Protein Summary

GFPT1 is a 699-amino acid protein that forms homodimers and catalyzes the first and rate-limiting step of the hexosamine biosynthesis pathway. It is allosterically inhibited by UDP-N-acetylglucosamine. The protein is ubiquitously expressed, with highest levels in skeletal muscle, heart, and liver. Alternative splicing generates isoforms with varying tissue distribution.

Related Products

Product name Cat.No. Species Gene ID
GFPT1 Knockout HEK293 Cell Line EDJ-KQ4700 Human 2673 Details Get a Quote
GFPT1 Knockout A-549 Cell Line EDJ-KQ26171 Human 2673 Details Get a Quote
GFPT1 Knockout HCT 116 Cell Line EDJ-KQ27412 Human 2673 Details Get a Quote
GFPT1 Knockout HeLa Cell Line EDJ-KQ27413 Human 2673 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: